Holly Villamagna, MD

Placeholder photo for missing headshot

Holly Villamagna, MD
Assistant Professor of Medicine
Division of Infectious Diseases, OHSU

Degrees

BA, University of Southern California, 2011
MD, University of Nevada, Reno School of Medicine, 2015

Residency

Internal Medicine, University of Nevada, Las Vegas 2018

Fellowship

Infectious Diseases, Oregon Health & Science University, 2020
Leadership in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship, 2021

Board Certification

American Board of Internal Medicine, 2018
American Board of Internal Medicine, Infectious Diseases, 2020

Biography

After earning a degree in print journalism at USC, Dr. Villamagna completed medical school and internal medicine residency in her home state of Nevada, followed by ID fellowship at OHSU. She subsequently participated in the Leadership in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship, during which she worked with Oregon Health Authority to complete a research project studying risk factors for large COVID outbreaks in long-term care facilities.

Dr. Villamagna’s clinical interests include inpatient and outpatient general infectious diseases. She is passionate about improving communication in medicine and has pursued that interest by working on clinical infectious diseases/public health collaborative projects as well as medical education projects focusing on medical student curriculum design and implementation. In her spare time, she enjoys running marathons (slowly), riding her Peloton bike, telling anyone who will listen about running and Peloton, and exploring the world with her husband and their Westie puppy Oliver.  

Selected Publications

  1. Villamagna AH, Bonura EM.  Infectious diseases simulation for medical students: experiential instruction on personal protective equipment.  MedEdPORTAL. 2020;16:11031.  https://doi.org/10.15766/mep_2374-8265.11031
  2. Fontana LM, Villamagna AH, Sikka MK, McGregor JC. Understanding viral shedding of severe acute respiratory coronavirus virus 2 (SARS-CoV-2): Review of current literature. Infect Control Hosp Epidemiol. 2021 Jun;42(6):659-668. https://doi.org/10.1017/ice.2020.1273
  3. Villamagna AH, Gore SJ, Lewis JS, Doggett JS. The Need for Antiviral Drugs for Pandemic Coronaviruses From a Global Health Perspective. Front Med (Lausanne). 2020 Dec 22;7:596587. https://doi.org/10.3389/fmed.2020.596587